(Q45767864)

English

Prospective observational study of imatinib therapy in Japanese patients with advanced gastrointestinal stromal tumors: long-term follow-up and second malignancy

scientific article published on 21 April 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22523393

Prospective observational study of imatinib therapy in Japanese patients with advanced gastrointestinal stromal tumors: long-term follow-up and second malignancy (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22523393

1 reference

based on heuristic

inferred from title

Takashi Ishikawa

2

object named as

Takashi Ishikawa

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22523393

author name string

Tatsuo Kanda

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22523393

Seiichi Hirota

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22523393

Kazuhito Yajima

4

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22523393

Shin-ichi Kosugi

5

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22523393

Manabu Ohashi

6

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22523393

Satoshi Suzuki

7

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22523393

Yasuoki Mashima

8

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22523393

Yoichi Ajioka

9

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22523393

Katsuyoshi Hatakeyama

10

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22523393

publication date

21 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22523393

Japanese Journal of Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22523393

42

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22523393

7

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22523393

578-585

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22523393

copyright license

Creative Commons Attribution-NonCommercial 4.0 International

4 October 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Survival of patients with multiple primary malignancies: a study of 783 patients with gastrointestinal stromal tumor

1 reference

https://pubmed.ncbi.nlm.nih.gov/22523393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Occurrence of other malignancies in patients with gastrointestinal stromal tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/22523393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Co-existence of gastrointestinal stromal tumors with other primary neoplasms

1 reference

https://pubmed.ncbi.nlm.nih.gov/22523393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imatinib plasma levels are correlated with clinical benefit in patients with unresectable/metastatic gastrointestinal stromal tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22523393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate

1 reference

https://pubmed.ncbi.nlm.nih.gov/22523393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of tyrosine kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor

1 reference

https://pubmed.ncbi.nlm.nih.gov/22523393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer Incidence and Incidence Rates in Japan in 2005: Based on Data from 12 Population-based Cancer Registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project

1 reference

https://pubmed.ncbi.nlm.nih.gov/22523393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/22523393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor

1 reference

https://pubmed.ncbi.nlm.nih.gov/22523393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/22523393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22523393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/22523393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surgery of residual disease following molecular-targeted therapy with imatinib mesylate in advanced/metastatic GIST.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22523393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The gap between clinical trials and clinical practice: the use of pragmatic clinical trials to inform regulatory decision making

1 reference

https://pubmed.ncbi.nlm.nih.gov/22523393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/22523393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective, multicenter, phase 2 study of imatinib mesylate in korean patients with metastatic or unresectable gastrointestinal stromal tumor

1 reference

https://pubmed.ncbi.nlm.nih.gov/22523393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/22523393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22523393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22523393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastrointestinal stromal tumor (GIST) and imatinib

1 reference

https://pubmed.ncbi.nlm.nih.gov/22523393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://pubmed.ncbi.nlm.nih.gov/22523393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety profile of imatinib mesylate (ST1571) in Japanese patients with advanced gastrointestinal stromal tumors: a phase II study (STI571B1202).

1 reference

https://pubmed.ncbi.nlm.nih.gov/22523393

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/JJCO/HYS056

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22523393

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

http://europepmc.org/abstract/MED/22523393

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45767864&oldid=2082027460"